The evolution of non-surgical management in stage III non-small cell lung cancer

Milit S Patel, Alessandro Hammond, Edward Christopher Dee, Puneeth Iyengar · 2026

Read The evolution of non-surgical management in stage III non-small cell lung cancer by Milit S Patel, Alessandro Hammond, Edward Christopher Dee, Puneeth Iyengar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13234163.txt.

Description

Milit S Patel and colleagues published a 2026 debate article on treating stage III lung cancer that cannot be removed surgically. For years the standard has been chemotherapy and radiation together, followed by a year of the immunotherapy drug durvalumab, a sequence set by the PACIFIC trial. The authors argue that this one-size-fits-all recipe no longer fits the evidence.

Tumors with particular molecular fingerprints may answer better to targeted drugs or different drug combinations, and the order of treatments could matter as much as the ingredients. The article weighs biomarker-guided refinement, novel immunotherapy pairings, and alternative sequencing for specific patient groups. It reads as a companion piece to debates over surgery in the same disease stage, mapping how non-surgical care is fragmenting into molecularly defined lanes.

Catalog record

CREATORMilit S Patel, Alessandro Hammond, Edward Christopher Dee, Puneeth Iyengar
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13234163

Browse the full library · About the Tower of Babel